Virtual Presentation

Evolving Options for First-line PI-Based Antiretroviral Regimens

Source: Evolving Options for First-line PI-Based Antiretroviral Regimens

Evolving Options for First-line PI-Based Antiretroviral Regimens

Faculty:

Douglas Ward, MD

CREDIT INFORMATION

Release Date: February 25, 2009

Expiration Date: February 24, 2010

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.1 Nursing contact hours

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Recount recent clinical trial data directly comparing the virologic efficacy of NNRTI- vs PI-based regimens for the initial treatment of HIV infection
Compare and contrast virologic efficacy and toxicity associated with PI-based first-line regimens according to the latest data from randomized clinical trials
Apply efficacy and safety data from comparative clinical trials of PI-based antiretroviral regimens as well as agent-specific factors such as pill burden and dosing schedule to the individualized selection of optimal PI-based regimens for the first-line treatment of HIV-infected patients
Distinguish among deintensification strategies aimed at simplifying treatment or reducing toxicities with PI-based regimens

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.